Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-27
Pages: 164 Pages
Report ld: 6388308
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Heart Failure Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
The goal of heart failure device treatment is to intervene in these three functional disorders. This usually includes repairing or improving heart structure through anatomical means, using electrophysiological techniques to manage arrhythmias, or enhancing myocardial contractility through mechanical support to improve the heart's pumping function. At the same time, since most heart failures start with left ventricular dysfunction, causing pulmonary congestion, heart failure patients may also experience respiratory failure. Therefore, mechanical support devices can also assist respiratory function and help relieve heart failure symptoms.
According to the treatment principle of the device, the existing heart failure devices on the market can be divided into three categories: mechanical assistance, electrical-related technology and structural improvement. In the future, with the influence of factors such as doctor recognition, accelerated population aging and improved affordability, the market for heart failure devices will further expand.
From a downstream perspective, GradeⅠ- Ⅳ accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Heart Failure Devices leading manufacturers (including Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, Impulse Dynamics, SynCardia, Berlin Heart, Covia Medica, V-Wave, etc.), dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Heart Failure Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Abbott
- Medtronic
- Jarvik Heart
- Abiomed
- Boston Scientific
- Impulse Dynamics
- SynCardia
- Berlin Heart
- Covia Medica
- V-Wave
- Evaheart
- BrioHealth Solutions
- Hanyu Medical
- NewMed Medical
- Valgen Medtech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Mechanical Assistance Type
- Electrical Related Technology
- Structural Improvement Type
Segment by Application
- GradeⅠ- Ⅳ
- Grade Ⅱ- Ⅳ
- Grade Ⅲ -IV
CHAPTER OUTLINE
Chapter 1: Defines the Heart Failure Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Heart Failure Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Heart Failure Devices Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Mechanical Assistance Type
1.2.3 Electrical Related Technology
1.2.4 Structural Improvement Type
1.3 Market Segmentation by Application
1.3.1 Global Heart Failure Devices Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 GradeⅠ- Ⅳ
1.3.3 Grade Ⅱ- Ⅳ
1.3.4 Grade Ⅲ -IV
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Heart Failure Devices Revenue Estimates and Forecasts (2021-2032)
2.2 Global Heart Failure Devices Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Heart Failure Devices Sales Estimates and Forecasts (2021-2032)
2.4 Global Heart Failure Devices Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Heart Failure Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Heart Failure Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Mechanical Assistance Type: Market Share by Key Manufacturers
3.5.2 Electrical Related Technology: Market Share by Key Manufacturers
3.5.3 Structural Improvement Type: Market Share by Key Manufacturers
3.6 Global Heart Failure Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Heart Failure Devices Sales Performance by Type
4.1.1 Global Heart Failure Devices Sales Volume by Type (2021-2032)
4.1.2 Global Heart Failure Devices Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Heart Failure Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Heart Failure Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Heart Failure Devices Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Heart Failure Devices Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Heart Failure Devices Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Heart Failure Devices Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Heart Failure Devices Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Heart Failure Devices Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Heart Failure Devices Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Heart Failure Devices Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Heart Failure Devices Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Heart Failure Devices Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Heart Failure Devices Product Models, Descriptions and Specifications
11.1.4 Abbott Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Abbott Heart Failure Devices Sales by Product in 2025
11.1.6 Abbott Heart Failure Devices Sales by Application in 2025
11.1.7 Abbott Heart Failure Devices Sales by Geographic Area in 2025
11.1.8 Abbott Heart Failure Devices SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Heart Failure Devices Product Models, Descriptions and Specifications
11.2.4 Medtronic Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Medtronic Heart Failure Devices Sales by Product in 2025
11.2.6 Medtronic Heart Failure Devices Sales by Application in 2025
11.2.7 Medtronic Heart Failure Devices Sales by Geographic Area in 2025
11.2.8 Medtronic Heart Failure Devices SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Jarvik Heart
11.3.1 Jarvik Heart Corporation Information
11.3.2 Jarvik Heart Business Overview
11.3.3 Jarvik Heart Heart Failure Devices Product Models, Descriptions and Specifications
11.3.4 Jarvik Heart Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Jarvik Heart Heart Failure Devices Sales by Product in 2025
11.3.6 Jarvik Heart Heart Failure Devices Sales by Application in 2025
11.3.7 Jarvik Heart Heart Failure Devices Sales by Geographic Area in 2025
11.3.8 Jarvik Heart Heart Failure Devices SWOT Analysis
11.3.9 Jarvik Heart Recent Developments
11.4 Abiomed
11.4.1 Abiomed Corporation Information
11.4.2 Abiomed Business Overview
11.4.3 Abiomed Heart Failure Devices Product Models, Descriptions and Specifications
11.4.4 Abiomed Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Abiomed Heart Failure Devices Sales by Product in 2025
11.4.6 Abiomed Heart Failure Devices Sales by Application in 2025
11.4.7 Abiomed Heart Failure Devices Sales by Geographic Area in 2025
11.4.8 Abiomed Heart Failure Devices SWOT Analysis
11.4.9 Abiomed Recent Developments
11.5 Boston Scientific
11.5.1 Boston Scientific Corporation Information
11.5.2 Boston Scientific Business Overview
11.5.3 Boston Scientific Heart Failure Devices Product Models, Descriptions and Specifications
11.5.4 Boston Scientific Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Boston Scientific Heart Failure Devices Sales by Product in 2025
11.5.6 Boston Scientific Heart Failure Devices Sales by Application in 2025
11.5.7 Boston Scientific Heart Failure Devices Sales by Geographic Area in 2025
11.5.8 Boston Scientific Heart Failure Devices SWOT Analysis
11.5.9 Boston Scientific Recent Developments
11.6 Impulse Dynamics
11.6.1 Impulse Dynamics Corporation Information
11.6.2 Impulse Dynamics Business Overview
11.6.3 Impulse Dynamics Heart Failure Devices Product Models, Descriptions and Specifications
11.6.4 Impulse Dynamics Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Impulse Dynamics Recent Developments
11.7 SynCardia
11.7.1 SynCardia Corporation Information
11.7.2 SynCardia Business Overview
11.7.3 SynCardia Heart Failure Devices Product Models, Descriptions and Specifications
11.7.4 SynCardia Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 SynCardia Recent Developments
11.8 Berlin Heart
11.8.1 Berlin Heart Corporation Information
11.8.2 Berlin Heart Business Overview
11.8.3 Berlin Heart Heart Failure Devices Product Models, Descriptions and Specifications
11.8.4 Berlin Heart Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Berlin Heart Recent Developments
11.9 Covia Medica
11.9.1 Covia Medica Corporation Information
11.9.2 Covia Medica Business Overview
11.9.3 Covia Medica Heart Failure Devices Product Models, Descriptions and Specifications
11.9.4 Covia Medica Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Covia Medica Recent Developments
11.10 V-Wave
11.10.1 V-Wave Corporation Information
11.10.2 V-Wave Business Overview
11.10.3 V-Wave Heart Failure Devices Product Models, Descriptions and Specifications
11.10.4 V-Wave Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 V-Wave Recent Developments
11.11 Evaheart
11.11.1 Evaheart Corporation Information
11.11.2 Evaheart Business Overview
11.11.3 Evaheart Heart Failure Devices Product Models, Descriptions and Specifications
11.11.4 Evaheart Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Evaheart Recent Developments
11.12 BrioHealth Solutions
11.12.1 BrioHealth Solutions Corporation Information
11.12.2 BrioHealth Solutions Business Overview
11.12.3 BrioHealth Solutions Heart Failure Devices Product Models, Descriptions and Specifications
11.12.4 BrioHealth Solutions Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 BrioHealth Solutions Recent Developments
11.13 Hanyu Medical
11.13.1 Hanyu Medical Corporation Information
11.13.2 Hanyu Medical Business Overview
11.13.3 Hanyu Medical Heart Failure Devices Product Models, Descriptions and Specifications
11.13.4 Hanyu Medical Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Hanyu Medical Recent Developments
11.14 NewMed Medical
11.14.1 NewMed Medical Corporation Information
11.14.2 NewMed Medical Business Overview
11.14.3 NewMed Medical Heart Failure Devices Product Models, Descriptions and Specifications
11.14.4 NewMed Medical Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 NewMed Medical Recent Developments
11.15 Valgen Medtech
11.15.1 Valgen Medtech Corporation Information
11.15.2 Valgen Medtech Business Overview
11.15.3 Valgen Medtech Heart Failure Devices Product Models, Descriptions and Specifications
11.15.4 Valgen Medtech Heart Failure Devices Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Valgen Medtech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Heart Failure Devices Industry Chain
12.2 Heart Failure Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Heart Failure Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Heart Failure Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Heart Failure Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Heart Failure Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Heart Failure Devices Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Heart Failure Devices Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Heart Failure Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Heart Failure Devices Revenue by Region (US$ Million), 2021-2026
Table 5. Global Heart Failure Devices Revenue by Region (US$ Million), 2027-2032
Table 6. Global Heart Failure Devices Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Units)
Table 7. Global Heart Failure Devices Sales by Region (Units), 2021-2026
Table 8. Global Heart Failure Devices Sales by Region (Units), 2027-2032
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 10. Global Heart Failure Devices Sales by Manufacturers (Units), 2021-2026
Table 11. Global Heart Failure Devices Sales Share by Manufacturers (2021-2026)
Table 12. Global Heart Failure Devices Revenue by Manufacturers (US$ Million), 2021-2026
Table 13. Global Heart Failure Devices Revenue-Based Market Share by Manufacturers (2021-2026)
Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Heart Failure Devices Revenue, 2025
Table 16. Global Heart Failure Devices Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 17. Global Heart Failure Devices Average Selling Price (ASP) by Manufacturers (K US$/Unit), 2021-2026
Table 18. Key Manufacturers Heart Failure Devices Manufacturing Base and Headquarters
Table 19. Global Heart Failure Devices Market Concentration Ratio (CR5)
Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Heart Failure Devices Sales Volume by Type (Units), 2021-2026
Table 23. Global Heart Failure Devices Sales Volume by Type (Units), 2027-2032
Table 24. Global Heart Failure Devices Revenue by Type (US$ Million), 2021-2026
Table 25. Global Heart Failure Devices Revenue by Type (US$ Million), 2027-2032
Table 26. Technical Specifications by Key Product Type
Table 27. Global Heart Failure Devices Sales by Application (Units), 2021-2026
Table 28. Global Heart Failure Devices Sales by Application (Units), 2027-2032
Table 29. Heart Failure Devices High-Growth Sectors Demand CAGR (2026-2032)
Table 30. Global Heart Failure Devices Revenue by Application (US$ Million), 2021-2026
Table 31. Global Heart Failure Devices Revenue by Application (US$ Million), 2027-2032
Table 32. Top Customers by Region
Table 33. Top Customers by Application
Table 34. North America Heart Failure Devices Growth Accelerators and Market Barriers
Table 35. North America Heart Failure Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 36. North America Heart Failure Devices Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 37. Europe Heart Failure Devices Growth Accelerators and Market Barriers
Table 38. Europe Heart Failure Devices Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Europe Heart Failure Devices Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 40. Asia-Pacific Heart Failure Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Asia-Pacific Heart Failure Devices Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 42. Asia-Pacific Heart Failure Devices Growth Accelerators and Market Barriers
Table 43. Southeast Asia Heart Failure Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Central and South America Heart Failure Devices Investment Opportunities and Key Challenges
Table 45. Central and South America Heart Failure Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. Middle East and Africa Heart Failure Devices Investment Opportunities and Key Challenges
Table 47. Middle East and Africa Heart Failure Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 48. Abbott Corporation Information
Table 49. Abbott Description and Major Businesses
Table 50. Abbott Product Models, Descriptions and Specifications
Table 51. Abbott Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 52. Abbott Sales Value Proportion by Product in 2025
Table 53. Abbott Sales Value Proportion by Application in 2025
Table 54. Abbott Sales Value Proportion by Geographic Area in 2025
Table 55. Abbott Heart Failure Devices SWOT Analysis
Table 56. Abbott Recent Developments
Table 57. Medtronic Corporation Information
Table 58. Medtronic Description and Major Businesses
Table 59. Medtronic Product Models, Descriptions and Specifications
Table 60. Medtronic Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 61. Medtronic Sales Value Proportion by Product in 2025
Table 62. Medtronic Sales Value Proportion by Application in 2025
Table 63. Medtronic Sales Value Proportion by Geographic Area in 2025
Table 64. Medtronic Heart Failure Devices SWOT Analysis
Table 65. Medtronic Recent Developments
Table 66. Jarvik Heart Corporation Information
Table 67. Jarvik Heart Description and Major Businesses
Table 68. Jarvik Heart Product Models, Descriptions and Specifications
Table 69. Jarvik Heart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 70. Jarvik Heart Sales Value Proportion by Product in 2025
Table 71. Jarvik Heart Sales Value Proportion by Application in 2025
Table 72. Jarvik Heart Sales Value Proportion by Geographic Area in 2025
Table 73. Jarvik Heart Heart Failure Devices SWOT Analysis
Table 74. Jarvik Heart Recent Developments
Table 75. Abiomed Corporation Information
Table 76. Abiomed Description and Major Businesses
Table 77. Abiomed Product Models, Descriptions and Specifications
Table 78. Abiomed Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 79. Abiomed Sales Value Proportion by Product in 2025
Table 80. Abiomed Sales Value Proportion by Application in 2025
Table 81. Abiomed Sales Value Proportion by Geographic Area in 2025
Table 82. Abiomed Heart Failure Devices SWOT Analysis
Table 83. Abiomed Recent Developments
Table 84. Boston Scientific Corporation Information
Table 85. Boston Scientific Description and Major Businesses
Table 86. Boston Scientific Product Models, Descriptions and Specifications
Table 87. Boston Scientific Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 88. Boston Scientific Sales Value Proportion by Product in 2025
Table 89. Boston Scientific Sales Value Proportion by Application in 2025
Table 90. Boston Scientific Sales Value Proportion by Geographic Area in 2025
Table 91. Boston Scientific Heart Failure Devices SWOT Analysis
Table 92. Boston Scientific Recent Developments
Table 93. Impulse Dynamics Corporation Information
Table 94. Impulse Dynamics Description and Major Businesses
Table 95. Impulse Dynamics Product Models, Descriptions and Specifications
Table 96. Impulse Dynamics Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 97. Impulse Dynamics Recent Developments
Table 98. SynCardia Corporation Information
Table 99. SynCardia Description and Major Businesses
Table 100. SynCardia Product Models, Descriptions and Specifications
Table 101. SynCardia Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 102. SynCardia Recent Developments
Table 103. Berlin Heart Corporation Information
Table 104. Berlin Heart Description and Major Businesses
Table 105. Berlin Heart Product Models, Descriptions and Specifications
Table 106. Berlin Heart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 107. Berlin Heart Recent Developments
Table 108. Covia Medica Corporation Information
Table 109. Covia Medica Description and Major Businesses
Table 110. Covia Medica Product Models, Descriptions and Specifications
Table 111. Covia Medica Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 112. Covia Medica Recent Developments
Table 113. V-Wave Corporation Information
Table 114. V-Wave Description and Major Businesses
Table 115. V-Wave Product Models, Descriptions and Specifications
Table 116. V-Wave Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 117. V-Wave Recent Developments
Table 118. Evaheart Corporation Information
Table 119. Evaheart Description and Major Businesses
Table 120. Evaheart Product Models, Descriptions and Specifications
Table 121. Evaheart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 122. Evaheart Recent Developments
Table 123. BrioHealth Solutions Corporation Information
Table 124. BrioHealth Solutions Description and Major Businesses
Table 125. BrioHealth Solutions Product Models, Descriptions and Specifications
Table 126. BrioHealth Solutions Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 127. BrioHealth Solutions Recent Developments
Table 128. Hanyu Medical Corporation Information
Table 129. Hanyu Medical Description and Major Businesses
Table 130. Hanyu Medical Product Models, Descriptions and Specifications
Table 131. Hanyu Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 132. Hanyu Medical Recent Developments
Table 133. NewMed Medical Corporation Information
Table 134. NewMed Medical Description and Major Businesses
Table 135. NewMed Medical Product Models, Descriptions and Specifications
Table 136. NewMed Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 137. NewMed Medical Recent Developments
Table 138. Valgen Medtech Corporation Information
Table 139. Valgen Medtech Description and Major Businesses
Table 140. Valgen Medtech Product Models, Descriptions and Specifications
Table 141. Valgen Medtech Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 142. Valgen Medtech Recent Developments
Table 143. Key Raw Materials Distribution
Table 144. Raw Materials Key Suppliers
Table 145. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 146. Milestones in Production Technology Evolution
Table 147. Distributors List
Table 148. Market Trends and Market Evolution
Table 149. Market Drivers and Opportunities
Table 150. Market Challenges, Risks, and Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Heart Failure Devices Product Picture
Figure 2. Global Heart Failure Devices Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Mechanical Assistance Type Product Picture
Figure 4. Electrical Related Technology Product Picture
Figure 5. Structural Improvement Type Product Picture
Figure 6. Global Heart Failure Devices Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. GradeⅠ- Ⅳ
Figure 8. Grade Ⅱ- Ⅳ
Figure 9. Grade Ⅲ -IV
Figure 10. Heart Failure Devices Report Years Considered
Figure 11. Global Heart Failure Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 13. Global Heart Failure Devices Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Global Heart Failure Devices Revenue-Based Market Share by Region (2021-2032)
Figure 15. Global Heart Failure Devices Sales (Units), 2021-2032
Figure 16. Global Heart Failure Devices Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Units)
Figure 17. Global Heart Failure Devices Sales Market Share by Region (2021-2032)
Figure 18. Top 5 and Top 10 Manufacturers Heart Failure Devices Sales Volume Market Share in 2025
Figure 19. Global Heart Failure Devices Revenue-Based Market Share Ranking (2025)
Figure 20. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 21. Mechanical Assistance Type Revenue-Based Market Share by Manufacturer in 2025
Figure 22. Electrical Related Technology Revenue-Based Market Share by Manufacturer in 2025
Figure 23. Structural Improvement Type Revenue-Based Market Share by Manufacturer in 2025
Figure 24. Global Heart Failure Devices Sales Volume-Based Market Share by Type (2021-2032)
Figure 25. Global Heart Failure Devices Revenue-Based Market Share by Type (2021-2032)
Figure 26. Global Heart Failure Devices ASP by Type (K US$/Unit), 2021-2032
Figure 27. Global Heart Failure Devices Revenue-Based Market Share (2021-2032)
Figure 28. Global Heart Failure Devices Sales Market Share by Application (2021-2032)
Figure 29. Global Heart Failure Devices Revenue-Based Market Share by Application (2021-2032)
Figure 30. Global Heart Failure Devices ASP by Application (K US$/Unit), 2021-2032
Figure 31. North America Heart Failure Devices Sales YoY (Units), 2021-2032
Figure 32. North America Heart Failure Devices Revenue YoY (US$ Million), 2021-2032
Figure 33. North America Top 5 Manufacturers Heart Failure Devices Sales Revenue (US$ Million) in 2025
Figure 34. North America Heart Failure Devices Sales Volume (Units) by Application (2021-2032)
Figure 35. North America Heart Failure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 36. US Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 37. Canada Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 38. Mexico Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 39. Europe Heart Failure Devices Sales YoY (Units), 2021-2032
Figure 40. Europe Heart Failure Devices Revenue YoY (US$ Million), 2021-2032
Figure 41. Europe Top 5 Manufacturers Heart Failure Devices Sales Revenue (US$ Million) in 2025
Figure 42. Europe Heart Failure Devices Sales Volume (Units) by Application (2021-2032)
Figure 43. Europe Heart Failure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 44. Germany Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 45. France Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 46. U.K. Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 47. Italy Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 48. Russia Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 49. Asia-Pacific Heart Failure Devices Sales YoY (Units), 2021-2032
Figure 50. Asia-Pacific Heart Failure Devices Revenue YoY (US$ Million), 2021-2032
Figure 51. Asia-Pacific Top 8 Manufacturers Heart Failure Devices Sales Revenue (US$ Million) in 2025
Figure 52. Asia-Pacific Heart Failure Devices Sales Volume (Units) by Application (2021-2032)
Figure 53. Asia-Pacific Heart Failure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 54. Indonesia Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 55. Japan Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 56. South Korea Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 57. China Taiwan Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 58. India Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 59. Central and South America Heart Failure Devices Sales YoY (Units), 2021-2032
Figure 60. Central and South America Heart Failure Devices Revenue YoY (US$ Million), 2021-2032
Figure 61. Central and South America Top 5 Manufacturers Heart Failure Devices Sales Revenue (US$ Million) in 2025
Figure 62. Central and South America Heart Failure Devices Sales Volume (Units) by Application (2021-2032)
Figure 63. Central and South America Heart Failure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 64. Brazil Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 65. Argentina Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 66. Middle East, and Africa Heart Failure Devices Sales YoY (Units), 2021-2032
Figure 67. Middle East and Africa Heart Failure Devices Revenue YoY (US$ Million), 2021-2032
Figure 68. Middle East and Africa Top 5 Manufacturers Heart Failure Devices Sales Revenue (US$ Million) in 2025
Figure 69. Middle East and Africa Heart Failure Devices Sales Volume (Units) by Application (2021-2032)
Figure 70. Middle East and Africa Heart Failure Devices Sales Revenue (US$ Million) by Application (2021-2032)
Figure 71. GCC Countries Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 72. Turkey Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 73. Egypt Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 74. South Africa Heart Failure Devices Revenue (US$ Million), 2021-2032
Figure 75. Heart Failure Devices Industry Chain Mapping
Figure 76. Regional Heart Failure Devices Manufacturing Base Distribution (%)
Figure 77. Global Heart Failure Devices Production Market Share by Region (2021-2032)
Figure 78. Heart Failure Devices Production Process
Figure 79. Regional Heart Failure Devices Production Cost Structure
Figure 80. Channels of Distribution (Direct Vs Distribution)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Heart Failure Devices market?
The top companies in the global Heart Failure Devices market are Abbott、Medtronic、Jarvik Heart.
Related Reports
Global Heart Failure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heart Failure Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 95
USD 4250.00
(Single User License)
Heart Failure Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heart Failure Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
Global Heart Failure Devices Market Research Report 2026
The global Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 123
USD 2900.00
(Single User License)
Global Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 161
USD 4900.00
(Single User License)
Global Heart Failure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 97
USD 4250.00
(Single User License)
Heart Failure Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 119
USD 3950.00
(Single User License)
Global Heart Failure Devices Market Research Report 2025
The global market for Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
Global and United States Heart Failure Devices Market Report & Forecast 2024-2030
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 123
USD 4350.00
(Single User License)
Global Heart Failure Devices Market Research Report 2024
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 96
USD 2900.00
(Single User License)
Global Heart Failure Devices Market Insights, Forecast to 2030
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 152
USD 4900.00
(Single User License)
Global Heart Failure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heart Failure Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 95
USD 4250.00 (Single User License)Heart Failure Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heart Failure Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 123
USD 3950.00 (Single User License)Global Heart Failure Devices Market Research Report 2026
The global Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 123
USD 2900.00 (Single User License)Global Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 161
USD 4900.00 (Single User License)Global Heart Failure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 97
USD 4250.00 (Single User License)Heart Failure Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 119
USD 3950.00 (Single User License)Global Heart Failure Devices Market Research Report 2025
The global market for Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 96
USD 2900.00 (Single User License)Global and United States Heart Failure Devices Market Report & Forecast 2024-2030
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 123
USD 4350.00 (Single User License)Global Heart Failure Devices Market Research Report 2024
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 96
USD 2900.00 (Single User License)Global Heart Failure Devices Market Insights, Forecast to 2030
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 152
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now